A New Gateway to the Proteome

March 19th, 2021 by

This 2 minute video provides an animated overview of Seer's proprietary nanoparticle technology for unbiased, deep, rapid proteomics at scale. Read More

US HUPO: Deep and rapid proteomics with the Protegraph Product Suite and the Bruker timsTOF platform

March 12th, 2021 by

Shadi Ferdosi, Ph.D. reviews the performance of the Proteograph Product Suite in combination with the Bruker timsTOF mass spectrometry platform using both DDA and DIA analysis. Read More

AACR: Identification of Differential Plasma Protein Isoforms in Early Lung Cancer

March 11th, 2021 by

From AACR 2021, this poster demonstrates that measurements at the peptide level for the plasma proteome enable quantification of differential isoform abundance patterns using the Proteograph Product Suite. Read More

ADPD: Proteograph Profiling of Alzheimer’s and Mild Cognitive Impairment Highlights Candidate Biomarkers

March 11th, 2021 by

John Blume, Ph.D., discusses how the Proteograph Product Suite can be used to identify novel and known candidate biomarkers in Alzheimers and Mild Cognitive Impairment (MCI) Read More

US HUPO: Deep plasma proteomics with trapped ion mobility and the Proteograph Product Suite

March 10th, 2021 by

Proteograph Product Suite in combination with the timsTOF Pro provides a high-performance combination for rapid deep, precise, and accurate proteome profiling for biomarker discovery and biomedical research Read More

ABRF: Cell‐Free DNA blood plasma for unbiased, deep, proteomics

March 8th, 2021 by

From ABRF 2021, this poster shows that plasma collected via cell-free DNA tubes can be used for unbiased, rapid, large-scale proteomic studies. Read More

AGBT: Unbiased Plasma Proteomics in Lung Cancer, Alzheimer’s Disease and Proteogenomics

March 1st, 2021 by

From AGBT 2021, a poster showing measurement of individual protein variants across the proteome, enabling unbiased proteogenomics at scale. Read More

HUPO: Comparison of Proteograph Product Suite to Traditional Peptide Fractionation

October 27th, 2020 by

Mark Flory, Ph.D. from Oregon Health Sciences University, Knight Cancer Institute, CEDAR shares a comparison of traditional deep proteomics by protein fractionation with the Seer Proteograph Product Suite Read More

Seer’s Nanoparticle Approach: A Novel Approach to Unbiased, Deep, Rapid and Scalable Proteomics

October 26th, 2020 by

Daniel Hornburg, Ph.D., Principal Scientist at Seer, provides a detailed overview of how Seer's proprietary engineered nanoparticles enable unbiased, deep proteomics that is rapid, easy to implement in any lab, and scalable to thousands of samples. Read More

The Challenge in Proteomics Today: Why We Need Unbiased, Deep, Rapid and Scalable Proteomics

October 20th, 2020 by

John Blume, Ph.D., discusses the current challenges in proteomics, the technological barriers we need to remove and how Seer’s Proteograph Product Suite is uniquely positioned to solve these challenges Read More